Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 111201-111250 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT03799107
Developmental Epidemiological Study of Children Born Through Reproductive Technology
N/A
Active, not recruiting
3,700 participants
Started: Jul 14, 2017 · Completed: Jul 1, 2025
6 conditions
2 sponsors
1 location
NCT03218761
POTS NET mRNA Functional Correlation With NET Activity
N/A
Active, not recruiting
200 participants
Started: Jul 14, 2017 · Completed: Dec 31, 2029
1 condition
3 sponsors
1 location
NCT03265431
Evaluation of PET/MR in Patients Selected for Ablation Therapy
PHASE2
Active, not recruiting
34 participants
Started: Jul 14, 2017 · Completed: Jun 30, 2027
1 condition
1 sponsor
1 location
NCT02650986
Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1
PHASE1/PHASE2
Active, not recruiting
15 participants
Started: Jul 14, 2017 · Completed: Jul 14, 2032
50 conditions
2 sponsors
1 location
NCT03334500
Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Prostate Cancer
EARLY_PHASE1
Active, not recruiting
30 participants
Started: Jul 14, 2017 · Completed: Jul 16, 2026
1 condition
1 sponsor
1 location
NCT03543215
Can Staging Magnetic Resonance Imaging (MRI) Features Prognosticate Patients Presenting With Endometrial Cancer?
N/A
Recruiting
500 participants
Started: Jul 13, 2017 · Completed: Dec 10, 2025
2 conditions
1 sponsor
1 location
NCT03173703
Evaluate Safety and Effectiveness of XenoSure® Biological Patch in the Application of Peripheral Vascular Repair
NA
Active, not recruiting
144 participants
Started: Jul 13, 2017 · Completed: Nov 15, 2025
1 condition
1 sponsor
1 location
NCT03220646
Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors
PHASE2
Active, not recruiting
64 participants
Started: Jul 13, 2017 · Completed: Jul 31, 2026
1 condition
2 sponsors
8 locations
NCT03400371
Biology of Juvenile Myoclonic Epilepsy
N/A
Recruiting
1,000 participants
Started: Jul 13, 2017 · Completed: Dec 31, 2026
1 condition
8 sponsors
15 locations
NCT03268668
Thrombus Composition in Ischemic Stroke: Analysis of the Correlation With Plasma Biomarkers, Efficacy of Treatment, Etiology and Prognosis
N/A
Recruiting
1,200 participants
Started: Jul 13, 2017 · Completed: Oct 31, 2027
5 conditions
1 sponsor
9 locations
NCT03155997
Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer
PHASE3
Active, not recruiting
5,637 participants
Started: Jul 12, 2017 · Completed: May 31, 2029
1 condition
2 sponsors
619 locations
NCT03916809
EMST in Patients Undergoing CRT for HNCA
NA
Recruiting
30 participants
Started: Jul 12, 2017 · Completed: Aug 1, 2025
2 conditions
3 sponsors
2 locations
NCT03191656
REDUCE LAP-HF III Corvia Protocol 1701
N/A
Recruiting
500 participants
Started: Jul 12, 2017 · Completed: Jul 31, 2028
1 condition
1 sponsor
27 locations
NCT03219359
Autologous Stem Cell Transplant for Crohn's Disease
PHASE2
Recruiting
50 participants
Started: Jul 12, 2017 · Completed: Apr 30, 2026
1 condition
1 sponsor
1 location
NCT03735797
Cancer Stem Cells in Acute Leukemia
N/A
Active, not recruiting
50 participants
Started: Jul 12, 2017 · Completed: Mar 1, 2026
1 condition
1 sponsor
2 locations
NCT03042104
EARLY TAVR: Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis
NA
Active, not recruiting
901 participants
Started: Jul 12, 2017 · Completed: Mar 31, 2032
2 conditions
1 sponsor
77 locations
NCT03169985
Randomized Controlled Trial of Moderate-Intensity Rosuvastatin With Ezetimibe Combination Therapy Versus High-Intensity Rosuvastatin on Progression of Coronary Atherosclerotic Plaque
PHASE4
Active, not recruiting
280 participants
Started: Jul 12, 2017 · Completed: Jan 28, 2027
1 condition
2 sponsors
1 location
NCT03044613
Nivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal Cancer
PHASE1
Active, not recruiting
32 participants
Started: Jul 11, 2017 · Completed: Aug 31, 2027
3 conditions
2 sponsors
3 locations
NCT03633201
Anatomic Congruent Prosthetic Knee Design
NA
Active, not recruiting
75 participants
Started: Jul 11, 2017 · Completed: Sep 1, 2026
1 condition
2 sponsors
1 location
NCT05954403
National Cohort on Congenital Defects of the Eye
N/A
Recruiting
800 participants
Started: Jul 11, 2017 · Completed: Jul 31, 2037
5 conditions
1 sponsor
1 location
NCT03169075
QUALIOR Feasibility and Efficacy of a Supervised Home-based Standard Physical Exercise Program
NA
Active, not recruiting
190 participants
Started: Jul 11, 2017 · Completed: Jul 11, 2028
2 conditions
2 sponsors
15 locations
NCT05927454
Acostill ( RaDiCo Cohort) (RaDiCo Acostill)
N/A
Recruiting
500 participants
Started: Jul 11, 2017 · Completed: Jul 31, 2027
3 conditions
1 sponsor
1 location
NCT03086421
Social Emotional Development in Young Children With Cancer
N/A
Active, not recruiting
119 participants
Started: Jul 11, 2017 · Completed: Jun 30, 2028
2 conditions
2 sponsors
1 location
NCT03217188
Proton Re-Irradiation for Recurrent Head and Neck Cancer
PHASE2
Active, not recruiting
87 participants
Started: Jul 10, 2017 · Completed: Jul 31, 2026
1 condition
1 sponsor
9 locations
NCT02682147
Functional CT Assessment of Pulmonary Arterial Dysfunction in Smoking Associated Emphysema
PHASE4
Active, not recruiting
17 participants
Started: Jul 10, 2017 · Completed: May 31, 2025
1 condition
3 sponsors
1 location
NCT03115086
The REPLACE Registry for Cholbam® (Cholic Acid)
N/A
Active, not recruiting
55 participants
Started: Jul 10, 2017 · Completed: Jul 31, 2039
1 condition
1 sponsor
23 locations
NCT03113929
Quantitative MRI for Non-invasive Assessment of Severity of Alcoholic Liver Disease (ALD)
N/A
Active, not recruiting
20 participants
Started: Jul 10, 2017 · Completed: Dec 1, 2025
1 condition
1 sponsor
1 location
NCT03213977
R-DA-EDOCH Versus R-CEOP90, With/Without Upfront Auto-HSCT in Young Patients With High-risk DLBCL
PHASE3
Active, not recruiting
475 participants
Started: Jul 10, 2017 · Completed: Jul 13, 2024
1 condition
1 sponsor
1 location
NCT03215719
Adaptive Treatment De-escalation in Favorable Risk HPV-Positive Oropharyngeal Carcinoma
PHASE2
Recruiting
144 participants
Started: Jul 10, 2017 · Completed: Dec 31, 2028
2 conditions
1 sponsor
1 location
NCT03253536
Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma
N/A
Recruiting
100 participants
Started: Jul 10, 2017 · Completed: Jul 10, 2027
4 conditions
1 sponsor
1 location
NCT03753334
Effects of EPA in Men With Biochemical Recurrence or Progression of Prostate Cancer.
PHASE2
Active, not recruiting
39 participants
Started: Jul 10, 2017 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03219502
rTMS in Improving Neuropathy in Patients With Stage I-IV Cancer Who Have Received Oxaliplatin Chemotherapy
NA
Active, not recruiting
56 participants
Started: Jul 10, 2017 · Completed: Apr 30, 2027
2 conditions
2 sponsors
1 location
NCT03984968
CD19 CAR-T Consolidation Therapy for Acute Lymphoblastic Leukemia
PHASE1/PHASE2
Recruiting
34 participants
Started: Jul 10, 2017 · Completed: Jan 24, 2040
1 condition
1 sponsor
1 location
NCT02969837
Study of Initial Treatment With Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone in Multiple Myeloma
PHASE2
Active, not recruiting
46 participants
Started: Jul 10, 2017 · Completed: Mar 1, 2027
1 condition
4 sponsors
3 locations
NCT03215095
RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers
EARLY_PHASE1
Active, not recruiting
11 participants
Started: Jul 10, 2017 · Completed: Jul 31, 2026
1 condition
3 sponsors
7 locations
NCT03171025
Adjuvant Nivolumab Following Chemo-Radiation in Localized Muscle-Invasive Bladder Cancer
PHASE2
Active, not recruiting
200 participants
Started: Jul 10, 2017 · Completed: Oct 31, 2027
1 condition
2 sponsors
2 locations
NCT03521648
Database for the Assessment of Efficacy and Safety of BPH Treatment
N/A
Recruiting
500 participants
Started: Jul 7, 2017 · Completed: Dec 1, 2027
2 conditions
1 sponsor
1 location
NCT02860000
Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer
PHASE2
Active, not recruiting
96 participants
Started: Jul 6, 2017 · Completed: Dec 31, 2026
9 conditions
2 sponsors
8 locations
NCT03171311
The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bifurcation Event Reduction (OCTOBER)
NA
Active, not recruiting
1,201 participants
Started: Jul 5, 2017 · Completed: May 31, 2029
2 conditions
2 sponsors
38 locations
NCT03976999
Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal Cancers
NA
Recruiting
300 participants
Started: Jul 5, 2017 · Completed: Jul 31, 2032
3 conditions
1 sponsor
1 location
NCT03184922
Fixed Versus Adjustable Loop in ACL Reconstruction
NA
Active, not recruiting
165 participants
Started: Jul 5, 2017 · Completed: Jan 31, 2026
1 condition
2 sponsors
1 location
NCT03194893
A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer
PHASE3
Active, not recruiting
200 participants
Started: Jul 5, 2017 · Completed: Oct 31, 2025
1 condition
1 sponsor
29 locations
NCT03214354
Nonmyeloablative Stem Cell Transplant in Children with Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor
PHASE2
Recruiting
12 participants
Started: Jul 5, 2017 · Completed: Jul 31, 2028
4 conditions
1 sponsor
1 location
NCT03040973
Study to Allow Patients Previously Participating in a Novartis Sponsored Trial to Continue Receiving Capmatinib Treatment as Single Agent or in Combination With Other Treatments or the Combination Treatment Alone
PHASE2
Active, not recruiting
29 participants
Started: Jul 4, 2017 · Completed: Jul 30, 2027
1 condition
1 sponsor
15 locations
NCT02905318
Palbociclib in Patients With Metastatic Castration-Resistant Prostate Cancer
PHASE2
Active, not recruiting
19 participants
Started: Jul 4, 2017 · Completed: Dec 30, 2025
1 condition
2 sponsors
7 locations
NCT02911142
Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma
PHASE1/PHASE2
Active, not recruiting
17 participants
Started: Jul 3, 2017 · Completed: Oct 1, 2027
2 conditions
1 sponsor
1 location
NCT03787771
The Fecal Microbiota Transplantation Registry
N/A
Recruiting
3,000 participants
Started: Jul 2, 2017 · Completed: Nov 30, 2046
1 condition
1 sponsor
1 location
NCT03198052
GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T Cells Against Cancers
PHASE1
Recruiting
30 participants
Started: Jul 1, 2017 · Completed: Aug 1, 2036
4 conditions
3 sponsors
2 locations
NCT07168330
Clinical and Radiological Evaluation of Total Ankle Replacement (ProtesiTT)
N/A
Recruiting
100 participants
Started: Jul 1, 2017 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT03422224
ALLoreactive T-Cell receptOr RePertoire in kidnEy tranSplantation
N/A
Recruiting
50 participants
Started: Jul 1, 2017 · Completed: Jul 31, 2024
4 conditions
1 sponsor
1 location
Previous
1
More pages
2222
2223
2224
2225
2226
2227
2228
More pages
2369
Next